MiR-210: A potential therapeutic target against radiation-induced enteropathy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24290534.
- Also identified by DOI 10.1016/j.radonc.2013.10.030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A previously undescribed and robust miR210 overexpression is shown in intestinal samples obtained from patients with radiation enteropathy and fibrotic cultured cells. In addition, miR-210 overexpression is repressed by antifibrotic treatment combining pentoxifylline and α-tocopherol.
Medical subject headings
- Intestinal Diseases
- MicroRNAs
- Pentoxifylline
- Platelet Aggregation Inhibitors
- Radiation Injuries
- Radiation-Protective Agents